Research map: Acromegaly and Metabolic Dysfunction–Associated Steatotic Liver Disease: Clinical and Therapeutic Implications

Back to the article

Papers in this map

  1. Acromegaly: An Endocrine Society Clinical Practice Guideline · Laurence J. Katznelson · 2014 · 1818 citations · Cited by this paper
  2. Cross-Sector Policies for Achieving Equitable Obesity Prevention and Food Security: A Review of Real-World Actions · 2026 · Related
  3. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach · Giovanni Targher · 2021 · 606 citations · Cited by this paper
  4. Emotional Eating and Obesity: An Update and New Insights · 2025 · Related
  5. Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines · Stergios Polyzos · 2009 · 334 citations · Cited by this paper
  6. Intersection between Eating Disorders and Obesity in Youth: Implications for Treatment · 2025 · Related
  7. The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease · Stergios A. Pοlyzos · 2009 · 280 citations · Cited by this paper
  8. The Role of Fathers in the Intergenerational Transmission of Obesity · 2026 · Related
  9. Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease · Evangelia S. Makri · 2020 · 214 citations · Cited by this paper
  10. Adult Growth Hormone Deficiency and Metabolic Dysfunction-Associated Steatotic Liver Disease · 2026 · Related
  11. Sarcopenic obesity · Stergios A. Pοlyzos · 2018 · 208 citations · Cited by this paper
  12. Obesogens in Prostate Cancer: An Endocrine and Metabolic Threat · 2026 · Related
  13. IGF1 Shapes Macrophage Activation in Response to Immunometabolic Challenge · Olga Spadaro · 2017 · 207 citations · Cited by this paper
  14. Effectiveness of Medical Nutrition Therapy in the Management of Patients with Obesity and Endometriosis: from the Mediterranean Diet To the Ketogenic Diet, Through Supplementation. The Role of the Nutritionist in Clinical Management · 2025 · Related
  15. Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults · Herbert Tilg · 2025 · 197 citations · Cited by this paper
  16. Two Sides of a Coin: Molecular, metabolic, and Phenotypic Convergence in Pediatric Undernutrition and Obesity · 2026 · Related
  17. The Intricate Role of Growth Hormone in Metabolism · Archana Vijayakumar · 2011 · 181 citations · Cited by this paper
  18. Non-invasive imaging diagnostic techniques in metabolic dysfunction-associated steatotic liver disease: a roadmap for clinicians · 2026 · Related
  19. IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner · Hitoshi Nishizawa · 2016 · 171 citations · Cited by this paper
  20. Role of insulin-like growth factor/receptor signaling in hepatocellular carcinoma · 2025 · Related
  21. Nonalcoholic Fatty Liver Disease · Stergios A. Pοlyzos · 2012 · 153 citations · Cited by this paper
  22. Lower Visceral and Subcutaneous but Higher Intermuscular Adipose Tissue Depots in Patients with Growth Hormone and Insulin-Like Growth Factor I Excess Due to Acromegaly · Pamela U. Freda · 2008 · 145 citations · Cited by this paper
  23. Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2 · Brandon Chin Sos · 2011 · 139 citations · Cited by this paper
  24. Glucose homeostasis in acromegaly: effects of long‐acting somatostatin analogues treatment · Roberto Baldelli · 2003 · 119 citations · Cited by this paper
  25. Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement · Stergios A. Pοlyzos · 2019 · 119 citations · Cited by this paper
  26. Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-β and STAT3 activation · Atsushi Hosui · 2009 · 118 citations · Cited by this paper
  27. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury · S. Sanz · 2004 · 117 citations · Cited by this paper
  28. Growth hormone in the aging male · Fred R. Sattler · 2013 · 116 citations · Cited by this paper
  29. The Emerging Role of Endocrine Disruptors in Pathogenesis of Insulin Resistance: A Concept Implicating Nonalcoholic Fatty Liver Disease · S. A. Polyzos · 2011 · 103 citations · Cited by this paper
  30. Review article: non‐alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations · Stergios A. Pοlyzos · 2021 · 94 citations · Cited by this paper
  31. Comparison between Six-Year Therapy with Long-Acting Somatostatin Analogs and Successful Surgery in Acromegaly: Effects on Cardiovascular Risk Factors · Cristina Lucia Ronchi · 2006 · 92 citations · Cited by this paper
  32. Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block · Vasilios Gabriel Athyros · 2019 · 86 citations · Cited by this paper
  33. Pegvisomant in acromegaly: an update · A. Giustina · 2017 · 85 citations · Cited by this paper
  34. Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study · Matina Kouvari · 2023 · 85 citations · Cited by this paper
  35. Mesenchymal Stromal Cells Engineered to Produce IGF-I by Recombinant Adenovirus Ameliorate Liver Fibrosis in Mice · Esteban Juan Fiore · 2014 · 80 citations · Cited by this paper
  36. Adipose Tissue Redistribution and Ectopic Lipid Deposition in Active Acromegaly and Effects of Surgical Treatment · Carlos M. Reyes-Vidal · 2015 · 80 citations · Cited by this paper
  37. Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy · Stergios A. Pοlyzos · 2023 · 77 citations · Cited by this paper
  38. Determinants of morbidities and mortality in acromegaly · Leandro Kasuki · 2019 · 67 citations · Cited by this paper
  39. Body Composition and Ectopic Lipid Changes With Biochemical Control of Acromegaly · Miriam A. Bredella · 2017 · 66 citations · Cited by this paper

Source: OpenAlex (CC0)